nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CA9—breast cancer	0.255	0.616	CbGaD
Methazolamide—CYP2D6—breast cancer	0.0857	0.207	CbGaD
Methazolamide—CYP3A4—breast cancer	0.0735	0.177	CbGaD
Methazolamide—CYP2C9—Anastrozole—breast cancer	0.0259	0.0756	CbGbCtD
Methazolamide—CYP2C19—Lapatinib—breast cancer	0.0208	0.0607	CbGbCtD
Methazolamide—CYP3A4—Exemestane—breast cancer	0.0199	0.058	CbGbCtD
Methazolamide—CYP2C9—Idarubicin—breast cancer	0.0196	0.0573	CbGbCtD
Methazolamide—CYP2D6—Idarubicin—breast cancer	0.018	0.0524	CbGbCtD
Methazolamide—CYP3A4—Letrozole—breast cancer	0.0169	0.0493	CbGbCtD
Methazolamide—CYP2E1—Tamoxifen—breast cancer	0.0166	0.0485	CbGbCtD
Methazolamide—CYP2E1—Mitoxantrone—breast cancer	0.0162	0.0473	CbGbCtD
Methazolamide—CYP3A4—Anastrozole—breast cancer	0.0151	0.044	CbGbCtD
Methazolamide—CYP3A4—Toremifene—breast cancer	0.0138	0.0402	CbGbCtD
Methazolamide—CYP3A4—Fulvestrant—breast cancer	0.0128	0.0374	CbGbCtD
Methazolamide—CYP3A4—Thiotepa—breast cancer	0.0114	0.0333	CbGbCtD
Methazolamide—CYP2C9—Capecitabine—breast cancer	0.0108	0.0314	CbGbCtD
Methazolamide—CYP3A4—Ixabepilone—breast cancer	0.0104	0.0305	CbGbCtD
Methazolamide—CYP2C19—Tamoxifen—breast cancer	0.0104	0.0304	CbGbCtD
Methazolamide—CYP3A4—Lapatinib—breast cancer	0.0101	0.0293	CbGbCtD
Methazolamide—CYP2D6—Vinorelbine—breast cancer	0.00877	0.0256	CbGbCtD
Methazolamide—CYP2C9—Tamoxifen—breast cancer	0.00866	0.0253	CbGbCtD
Methazolamide—CYP2D6—Tamoxifen—breast cancer	0.00792	0.0231	CbGbCtD
Methazolamide—SLC22A6—Methotrexate—breast cancer	0.00766	0.0224	CbGbCtD
Methazolamide—CYP3A4—Raloxifene—breast cancer	0.00762	0.0222	CbGbCtD
Methazolamide—CYP2C9—Paclitaxel—breast cancer	0.00674	0.0197	CbGbCtD
Methazolamide—CYP2C9—Fluorouracil—breast cancer	0.00638	0.0186	CbGbCtD
Methazolamide—CYP3A4—Vinorelbine—breast cancer	0.00558	0.0163	CbGbCtD
Methazolamide—CYP2D6—Vinblastine—breast cancer	0.00541	0.0158	CbGbCtD
Methazolamide—CYP3A4—Tamoxifen—breast cancer	0.00503	0.0147	CbGbCtD
Methazolamide—CYP3A4—Mitoxantrone—breast cancer	0.00491	0.0143	CbGbCtD
Methazolamide—CYP3A4—Paclitaxel—breast cancer	0.00392	0.0114	CbGbCtD
Methazolamide—CYP3A4—Irinotecan—breast cancer	0.00387	0.0113	CbGbCtD
Methazolamide—CYP3A4—Vinblastine—breast cancer	0.00344	0.01	CbGbCtD
Methazolamide—CYP2D6—Doxorubicin—breast cancer	0.00332	0.00969	CbGbCtD
Methazolamide—CYP3A4—Docetaxel—breast cancer	0.00283	0.00826	CbGbCtD
Methazolamide—Acetazolamide—CA9—breast cancer	0.00248	0.776	CrCbGaD
Methazolamide—CYP3A4—Doxorubicin—breast cancer	0.00211	0.00616	CbGbCtD
Methazolamide—CA5A—female reproductive system—breast cancer	0.00107	0.0617	CbGeAlD
Methazolamide—CA5B—mammary gland—breast cancer	0.000999	0.0578	CbGeAlD
Methazolamide—CA5A—endocrine gland—breast cancer	0.000902	0.0522	CbGeAlD
Methazolamide—Acetazolamide—CYP3A4—breast cancer	0.000714	0.224	CrCbGaD
Methazolamide—CA9—female reproductive system—breast cancer	0.000623	0.0361	CbGeAlD
Methazolamide—CA14—adrenal gland—breast cancer	0.000577	0.0334	CbGeAlD
Methazolamide—CA4—nipple—breast cancer	0.000571	0.033	CbGeAlD
Methazolamide—CA9—endocrine gland—breast cancer	0.000527	0.0305	CbGeAlD
Methazolamide—CYP2C9—mammary gland—breast cancer	0.000484	0.028	CbGeAlD
Methazolamide—CA2—nipple—breast cancer	0.000473	0.0274	CbGeAlD
Methazolamide—CA12—female reproductive system—breast cancer	0.000461	0.0267	CbGeAlD
Methazolamide—CA5B—adipose tissue—breast cancer	0.00045	0.026	CbGeAlD
Methazolamide—CA5B—female reproductive system—breast cancer	0.000413	0.0239	CbGeAlD
Methazolamide—CA5B—adrenal gland—breast cancer	0.000403	0.0233	CbGeAlD
Methazolamide—CA1—adipose tissue—breast cancer	0.000397	0.023	CbGeAlD
Methazolamide—CA2—embryo—breast cancer	0.00039	0.0226	CbGeAlD
Methazolamide—CA12—endocrine gland—breast cancer	0.00039	0.0226	CbGeAlD
Methazolamide—CA1—female reproductive system—breast cancer	0.000365	0.0211	CbGeAlD
Methazolamide—CA5B—endocrine gland—breast cancer	0.00035	0.0202	CbGeAlD
Methazolamide—CA1—bone marrow—breast cancer	0.000345	0.0199	CbGeAlD
Methazolamide—CA2—epithelium—breast cancer	0.000319	0.0184	CbGeAlD
Methazolamide—CA4—pituitary gland—breast cancer	0.000312	0.018	CbGeAlD
Methazolamide—CA4—adipose tissue—breast cancer	0.00031	0.018	CbGeAlD
Methazolamide—CA1—endocrine gland—breast cancer	0.000309	0.0179	CbGeAlD
Methazolamide—CA2—skin of body—breast cancer	0.000303	0.0175	CbGeAlD
Methazolamide—CA4—female reproductive system—breast cancer	0.000285	0.0165	CbGeAlD
Methazolamide—CA4—adrenal gland—breast cancer	0.000278	0.0161	CbGeAlD
Methazolamide—CA4—bone marrow—breast cancer	0.000269	0.0156	CbGeAlD
Methazolamide—CA4—female gonad—breast cancer	0.00026	0.015	CbGeAlD
Methazolamide—CA2—pituitary gland—breast cancer	0.000258	0.015	CbGeAlD
Methazolamide—CA2—adipose tissue—breast cancer	0.000257	0.0149	CbGeAlD
Methazolamide—CA5B—lymph node—breast cancer	0.000242	0.014	CbGeAlD
Methazolamide—CA4—endocrine gland—breast cancer	0.000241	0.014	CbGeAlD
Methazolamide—CA2—female reproductive system—breast cancer	0.000237	0.0137	CbGeAlD
Methazolamide—CA2—adrenal gland—breast cancer	0.000231	0.0134	CbGeAlD
Methazolamide—CA2—bone marrow—breast cancer	0.000223	0.0129	CbGeAlD
Methazolamide—CYP2C19—endocrine gland—breast cancer	0.000219	0.0126	CbGeAlD
Methazolamide—CA2—female gonad—breast cancer	0.000215	0.0125	CbGeAlD
Methazolamide—CA1—lymph node—breast cancer	0.000214	0.0124	CbGeAlD
Methazolamide—CA2—endocrine gland—breast cancer	0.0002	0.0116	CbGeAlD
Methazolamide—CYP2C9—female reproductive system—breast cancer	0.0002	0.0116	CbGeAlD
Methazolamide—CYP2E1—female reproductive system—breast cancer	0.00019	0.011	CbGeAlD
Methazolamide—CYP2E1—adrenal gland—breast cancer	0.000185	0.0107	CbGeAlD
Methazolamide—CYP2C9—endocrine gland—breast cancer	0.000169	0.0098	CbGeAlD
Methazolamide—CA4—lymph node—breast cancer	0.000167	0.00966	CbGeAlD
Methazolamide—CYP2E1—endocrine gland—breast cancer	0.000161	0.00929	CbGeAlD
Methazolamide—CYP3A4—female reproductive system—breast cancer	0.000153	0.00883	CbGeAlD
Methazolamide—CYP2D6—female reproductive system—breast cancer	0.00015	0.00869	CbGeAlD
Methazolamide—CA2—lymph node—breast cancer	0.000138	0.00801	CbGeAlD
Methazolamide—CYP2D6—female gonad—breast cancer	0.000137	0.00791	CbGeAlD
Methazolamide—CYP3A4—endocrine gland—breast cancer	0.000129	0.00748	CbGeAlD
Methazolamide—CYP2D6—endocrine gland—breast cancer	0.000127	0.00736	CbGeAlD
Methazolamide—Headache—Tamoxifen—breast cancer	0.000119	0.000871	CcSEcCtD
Methazolamide—Vomiting—Melphalan—breast cancer	0.000118	0.000866	CcSEcCtD
Methazolamide—Dyspepsia—Mitoxantrone—breast cancer	0.000118	0.000864	CcSEcCtD
Methazolamide—Dyspepsia—Irinotecan—breast cancer	0.000118	0.000864	CcSEcCtD
Methazolamide—Tinnitus—Capecitabine—breast cancer	0.000117	0.000862	CcSEcCtD
Methazolamide—Rash—Melphalan—breast cancer	0.000117	0.000859	CcSEcCtD
Methazolamide—Paraesthesia—Gemcitabine—breast cancer	0.000117	0.000858	CcSEcCtD
Methazolamide—Dermatitis—Melphalan—breast cancer	0.000117	0.000858	CcSEcCtD
Methazolamide—Asthenia—Vinorelbine—breast cancer	0.000116	0.000854	CcSEcCtD
Methazolamide—Decreased appetite—Mitoxantrone—breast cancer	0.000116	0.000853	CcSEcCtD
Methazolamide—Decreased appetite—Irinotecan—breast cancer	0.000116	0.000853	CcSEcCtD
Methazolamide—Nausea—Vinblastine—breast cancer	0.000116	0.000851	CcSEcCtD
Methazolamide—Somnolence—Gemcitabine—breast cancer	0.000116	0.00085	CcSEcCtD
Methazolamide—Convulsion—Paclitaxel—breast cancer	0.000116	0.00085	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Irinotecan—breast cancer	0.000115	0.000847	CcSEcCtD
Methazolamide—Fatigue—Mitoxantrone—breast cancer	0.000115	0.000846	CcSEcCtD
Methazolamide—Fatigue—Irinotecan—breast cancer	0.000115	0.000846	CcSEcCtD
Methazolamide—Vomiting—Goserelin—breast cancer	0.000115	0.000845	CcSEcCtD
Methazolamide—Paraesthesia—Fluorouracil—breast cancer	0.000115	0.000844	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Epirubicin—breast cancer	0.000114	0.000838	CcSEcCtD
Methazolamide—Rash—Goserelin—breast cancer	0.000114	0.000838	CcSEcCtD
Methazolamide—Dermatitis—Goserelin—breast cancer	0.000114	0.000837	CcSEcCtD
Methazolamide—Somnolence—Fluorouracil—breast cancer	0.000114	0.000836	CcSEcCtD
Methazolamide—Headache—Goserelin—breast cancer	0.000113	0.000832	CcSEcCtD
Methazolamide—Decreased appetite—Gemcitabine—breast cancer	0.000113	0.000831	CcSEcCtD
Methazolamide—Dyspepsia—Fluorouracil—breast cancer	0.000113	0.000827	CcSEcCtD
Methazolamide—Nausea—Tamoxifen—breast cancer	0.000112	0.000826	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000112	0.000825	CcSEcCtD
Methazolamide—Discomfort—Paclitaxel—breast cancer	0.000112	0.000825	CcSEcCtD
Methazolamide—Fatigue—Gemcitabine—breast cancer	0.000112	0.000824	CcSEcCtD
Methazolamide—Decreased appetite—Fluorouracil—breast cancer	0.000111	0.000817	CcSEcCtD
Methazolamide—Pancytopenia—Methotrexate—breast cancer	0.000111	0.000817	CcSEcCtD
Methazolamide—Asthenia—Thiotepa—breast cancer	0.000111	0.000815	CcSEcCtD
Methazolamide—Diarrhoea—Vinorelbine—breast cancer	0.000111	0.000814	CcSEcCtD
Methazolamide—Dysgeusia—Docetaxel—breast cancer	0.000111	0.000814	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Fluorouracil—breast cancer	0.00011	0.000812	CcSEcCtD
Methazolamide—Nausea—Melphalan—breast cancer	0.00011	0.000809	CcSEcCtD
Methazolamide—Feeling abnormal—Mitoxantrone—breast cancer	0.00011	0.000809	CcSEcCtD
Methazolamide—Feeling abnormal—Irinotecan—breast cancer	0.00011	0.000809	CcSEcCtD
Methazolamide—Confusional state—Paclitaxel—breast cancer	0.00011	0.000807	CcSEcCtD
Methazolamide—Anaphylactic shock—Paclitaxel—breast cancer	0.000109	0.0008	CcSEcCtD
Methazolamide—Nausea—Goserelin—breast cancer	0.000107	0.000789	CcSEcCtD
Methazolamide—Dysgeusia—Capecitabine—breast cancer	0.000107	0.000788	CcSEcCtD
Methazolamide—Feeling abnormal—Gemcitabine—breast cancer	0.000107	0.000788	CcSEcCtD
Methazolamide—Photosensitivity reaction—Methotrexate—breast cancer	0.000107	0.000785	CcSEcCtD
Methazolamide—Urticaria—Mitoxantrone—breast cancer	0.000106	0.00078	CcSEcCtD
Methazolamide—Diarrhoea—Thiotepa—breast cancer	0.000106	0.000778	CcSEcCtD
Methazolamide—Body temperature increased—Irinotecan—breast cancer	0.000106	0.000776	CcSEcCtD
Methazolamide—Body temperature increased—Mitoxantrone—breast cancer	0.000106	0.000776	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000106	0.000776	CcSEcCtD
Methazolamide—Feeling abnormal—Fluorouracil—breast cancer	0.000105	0.000775	CcSEcCtD
Methazolamide—Drowsiness—Methotrexate—breast cancer	0.000104	0.000767	CcSEcCtD
Methazolamide—Pancytopenia—Epirubicin—breast cancer	0.000104	0.000764	CcSEcCtD
Methazolamide—Anorexia—Paclitaxel—breast cancer	0.000104	0.000763	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000103	0.00076	CcSEcCtD
Methazolamide—Vomiting—Vinorelbine—breast cancer	0.000103	0.000757	CcSEcCtD
Methazolamide—Body temperature increased—Gemcitabine—breast cancer	0.000103	0.000756	CcSEcCtD
Methazolamide—Rash—Vinorelbine—breast cancer	0.000102	0.00075	CcSEcCtD
Methazolamide—Dermatitis—Vinorelbine—breast cancer	0.000102	0.00075	CcSEcCtD
Methazolamide—Ill-defined disorder—Capecitabine—breast cancer	0.000102	0.000747	CcSEcCtD
Methazolamide—Urticaria—Fluorouracil—breast cancer	0.000102	0.000747	CcSEcCtD
Methazolamide—Headache—Vinorelbine—breast cancer	0.000101	0.000746	CcSEcCtD
Methazolamide—Leukopenia—Docetaxel—breast cancer	0.000101	0.000744	CcSEcCtD
Methazolamide—Body temperature increased—Fluorouracil—breast cancer	0.000101	0.000743	CcSEcCtD
Methazolamide—Photosensitivity reaction—Epirubicin—breast cancer	9.99e-05	0.000735	CcSEcCtD
Methazolamide—Haematuria—Methotrexate—breast cancer	9.94e-05	0.000731	CcSEcCtD
Methazolamide—Malaise—Capecitabine—breast cancer	9.87e-05	0.000726	CcSEcCtD
Methazolamide—Vertigo—Capecitabine—breast cancer	9.84e-05	0.000723	CcSEcCtD
Methazolamide—Vomiting—Thiotepa—breast cancer	9.83e-05	0.000723	CcSEcCtD
Methazolamide—Leukopenia—Capecitabine—breast cancer	9.8e-05	0.00072	CcSEcCtD
Methazolamide—Convulsion—Docetaxel—breast cancer	9.8e-05	0.00072	CcSEcCtD
Methazolamide—Paraesthesia—Paclitaxel—breast cancer	9.78e-05	0.000719	CcSEcCtD
Methazolamide—Drowsiness—Epirubicin—breast cancer	9.76e-05	0.000718	CcSEcCtD
Methazolamide—Rash—Thiotepa—breast cancer	9.75e-05	0.000717	CcSEcCtD
Methazolamide—Dermatitis—Thiotepa—breast cancer	9.74e-05	0.000716	CcSEcCtD
Methazolamide—Agranulocytosis—Methotrexate—breast cancer	9.73e-05	0.000715	CcSEcCtD
Methazolamide—Headache—Thiotepa—breast cancer	9.68e-05	0.000712	CcSEcCtD
Methazolamide—Somnolence—Paclitaxel—breast cancer	9.68e-05	0.000712	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Epirubicin—breast cancer	9.68e-05	0.000711	CcSEcCtD
Methazolamide—Pancytopenia—Doxorubicin—breast cancer	9.62e-05	0.000707	CcSEcCtD
Methazolamide—Nausea—Vinorelbine—breast cancer	9.61e-05	0.000707	CcSEcCtD
Methazolamide—Dyspepsia—Paclitaxel—breast cancer	9.58e-05	0.000705	CcSEcCtD
Methazolamide—Asthenia—Mitoxantrone—breast cancer	9.58e-05	0.000704	CcSEcCtD
Methazolamide—Asthenia—Irinotecan—breast cancer	9.58e-05	0.000704	CcSEcCtD
Methazolamide—Decreased appetite—Paclitaxel—breast cancer	9.46e-05	0.000696	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Paclitaxel—breast cancer	9.4e-05	0.000691	CcSEcCtD
Methazolamide—Fatigue—Paclitaxel—breast cancer	9.39e-05	0.00069	CcSEcCtD
Methazolamide—Asthenia—Gemcitabine—breast cancer	9.33e-05	0.000686	CcSEcCtD
Methazolamide—Haematuria—Epirubicin—breast cancer	9.31e-05	0.000684	CcSEcCtD
Methazolamide—Confusional state—Docetaxel—breast cancer	9.31e-05	0.000684	CcSEcCtD
Methazolamide—Photosensitivity reaction—Doxorubicin—breast cancer	9.24e-05	0.00068	CcSEcCtD
Methazolamide—Anaphylactic shock—Docetaxel—breast cancer	9.23e-05	0.000678	CcSEcCtD
Methazolamide—Discomfort—Capecitabine—breast cancer	9.21e-05	0.000677	CcSEcCtD
Methazolamide—Nausea—Thiotepa—breast cancer	9.18e-05	0.000675	CcSEcCtD
Methazolamide—Diarrhoea—Irinotecan—breast cancer	9.13e-05	0.000672	CcSEcCtD
Methazolamide—Diarrhoea—Mitoxantrone—breast cancer	9.13e-05	0.000672	CcSEcCtD
Methazolamide—Agranulocytosis—Epirubicin—breast cancer	9.11e-05	0.00067	CcSEcCtD
Methazolamide—Drowsiness—Doxorubicin—breast cancer	9.03e-05	0.000664	CcSEcCtD
Methazolamide—Confusional state—Capecitabine—breast cancer	9.01e-05	0.000662	CcSEcCtD
Methazolamide—Feeling abnormal—Paclitaxel—breast cancer	8.97e-05	0.00066	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Doxorubicin—breast cancer	8.95e-05	0.000658	CcSEcCtD
Methazolamide—Diarrhoea—Gemcitabine—breast cancer	8.9e-05	0.000654	CcSEcCtD
Methazolamide—Erythema multiforme—Methotrexate—breast cancer	8.85e-05	0.000651	CcSEcCtD
Methazolamide—Anorexia—Docetaxel—breast cancer	8.8e-05	0.000647	CcSEcCtD
Methazolamide—Diarrhoea—Fluorouracil—breast cancer	8.75e-05	0.000643	CcSEcCtD
Methazolamide—Tinnitus—Methotrexate—breast cancer	8.73e-05	0.000642	CcSEcCtD
Methazolamide—Urticaria—Paclitaxel—breast cancer	8.65e-05	0.000636	CcSEcCtD
Methazolamide—Haematuria—Doxorubicin—breast cancer	8.61e-05	0.000633	CcSEcCtD
Methazolamide—Body temperature increased—Paclitaxel—breast cancer	8.61e-05	0.000633	CcSEcCtD
Methazolamide—Anorexia—Capecitabine—breast cancer	8.52e-05	0.000626	CcSEcCtD
Methazolamide—Vomiting—Mitoxantrone—breast cancer	8.49e-05	0.000624	CcSEcCtD
Methazolamide—Vomiting—Irinotecan—breast cancer	8.49e-05	0.000624	CcSEcCtD
Methazolamide—Agranulocytosis—Doxorubicin—breast cancer	8.43e-05	0.00062	CcSEcCtD
Methazolamide—Rash—Irinotecan—breast cancer	8.42e-05	0.000619	CcSEcCtD
Methazolamide—Rash—Mitoxantrone—breast cancer	8.42e-05	0.000619	CcSEcCtD
Methazolamide—Dermatitis—Irinotecan—breast cancer	8.41e-05	0.000618	CcSEcCtD
Methazolamide—Dermatitis—Mitoxantrone—breast cancer	8.41e-05	0.000618	CcSEcCtD
Methazolamide—Headache—Mitoxantrone—breast cancer	8.36e-05	0.000615	CcSEcCtD
Methazolamide—Headache—Irinotecan—breast cancer	8.36e-05	0.000615	CcSEcCtD
Methazolamide—Paraesthesia—Docetaxel—breast cancer	8.29e-05	0.000609	CcSEcCtD
Methazolamide—Erythema multiforme—Epirubicin—breast cancer	8.28e-05	0.000609	CcSEcCtD
Methazolamide—Vomiting—Gemcitabine—breast cancer	8.27e-05	0.000608	CcSEcCtD
Methazolamide—Somnolence—Docetaxel—breast cancer	8.2e-05	0.000603	CcSEcCtD
Methazolamide—Rash—Gemcitabine—breast cancer	8.2e-05	0.000603	CcSEcCtD
Methazolamide—Dermatitis—Gemcitabine—breast cancer	8.19e-05	0.000602	CcSEcCtD
Methazolamide—Tinnitus—Epirubicin—breast cancer	8.17e-05	0.000601	CcSEcCtD
Methazolamide—Headache—Gemcitabine—breast cancer	8.15e-05	0.000599	CcSEcCtD
Methazolamide—Vomiting—Fluorouracil—breast cancer	8.13e-05	0.000598	CcSEcCtD
Methazolamide—Dyspepsia—Docetaxel—breast cancer	8.12e-05	0.000597	CcSEcCtD
Methazolamide—Rash—Fluorouracil—breast cancer	8.06e-05	0.000593	CcSEcCtD
Methazolamide—Dermatitis—Fluorouracil—breast cancer	8.05e-05	0.000592	CcSEcCtD
Methazolamide—Paraesthesia—Capecitabine—breast cancer	8.02e-05	0.00059	CcSEcCtD
Methazolamide—Decreased appetite—Docetaxel—breast cancer	8.02e-05	0.00059	CcSEcCtD
Methazolamide—Headache—Fluorouracil—breast cancer	8.01e-05	0.000589	CcSEcCtD
Methazolamide—Dysgeusia—Methotrexate—breast cancer	7.98e-05	0.000587	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Docetaxel—breast cancer	7.97e-05	0.000586	CcSEcCtD
Methazolamide—Fatigue—Docetaxel—breast cancer	7.96e-05	0.000585	CcSEcCtD
Methazolamide—Nausea—Mitoxantrone—breast cancer	7.93e-05	0.000583	CcSEcCtD
Methazolamide—Nausea—Irinotecan—breast cancer	7.93e-05	0.000583	CcSEcCtD
Methazolamide—Dyspepsia—Capecitabine—breast cancer	7.87e-05	0.000578	CcSEcCtD
Methazolamide—Asthenia—Paclitaxel—breast cancer	7.81e-05	0.000574	CcSEcCtD
Methazolamide—Decreased appetite—Capecitabine—breast cancer	7.77e-05	0.000571	CcSEcCtD
Methazolamide—Nausea—Gemcitabine—breast cancer	7.72e-05	0.000568	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Capecitabine—breast cancer	7.71e-05	0.000567	CcSEcCtD
Methazolamide—Fatigue—Capecitabine—breast cancer	7.7e-05	0.000566	CcSEcCtD
Methazolamide—Erythema multiforme—Doxorubicin—breast cancer	7.66e-05	0.000564	CcSEcCtD
Methazolamide—Feeling abnormal—Docetaxel—breast cancer	7.6e-05	0.000559	CcSEcCtD
Methazolamide—Nausea—Fluorouracil—breast cancer	7.59e-05	0.000558	CcSEcCtD
Methazolamide—Ill-defined disorder—Methotrexate—breast cancer	7.56e-05	0.000556	CcSEcCtD
Methazolamide—Tinnitus—Doxorubicin—breast cancer	7.56e-05	0.000556	CcSEcCtD
Methazolamide—Dysgeusia—Epirubicin—breast cancer	7.47e-05	0.000549	CcSEcCtD
Methazolamide—Diarrhoea—Paclitaxel—breast cancer	7.45e-05	0.000548	CcSEcCtD
Methazolamide—Feeling abnormal—Capecitabine—breast cancer	7.36e-05	0.000541	CcSEcCtD
Methazolamide—Malaise—Methotrexate—breast cancer	7.35e-05	0.00054	CcSEcCtD
Methazolamide—Vertigo—Methotrexate—breast cancer	7.32e-05	0.000538	CcSEcCtD
Methazolamide—Body temperature increased—Docetaxel—breast cancer	7.3e-05	0.000536	CcSEcCtD
Methazolamide—Leukopenia—Methotrexate—breast cancer	7.3e-05	0.000536	CcSEcCtD
Methazolamide—Urticaria—Capecitabine—breast cancer	7.1e-05	0.000522	CcSEcCtD
Methazolamide—Ill-defined disorder—Epirubicin—breast cancer	7.08e-05	0.00052	CcSEcCtD
Methazolamide—Body temperature increased—Capecitabine—breast cancer	7.06e-05	0.000519	CcSEcCtD
Methazolamide—Convulsion—Methotrexate—breast cancer	7.06e-05	0.000519	CcSEcCtD
Methazolamide—Vomiting—Paclitaxel—breast cancer	6.92e-05	0.000509	CcSEcCtD
Methazolamide—Dysgeusia—Doxorubicin—breast cancer	6.91e-05	0.000508	CcSEcCtD
Methazolamide—Malaise—Epirubicin—breast cancer	6.88e-05	0.000506	CcSEcCtD
Methazolamide—Rash—Paclitaxel—breast cancer	6.86e-05	0.000505	CcSEcCtD
Methazolamide—Dermatitis—Paclitaxel—breast cancer	6.86e-05	0.000504	CcSEcCtD
Methazolamide—Discomfort—Methotrexate—breast cancer	6.86e-05	0.000504	CcSEcCtD
Methazolamide—Vertigo—Epirubicin—breast cancer	6.85e-05	0.000504	CcSEcCtD
Methazolamide—Leukopenia—Epirubicin—breast cancer	6.83e-05	0.000502	CcSEcCtD
Methazolamide—Headache—Paclitaxel—breast cancer	6.82e-05	0.000501	CcSEcCtD
Methazolamide—Confusional state—Methotrexate—breast cancer	6.71e-05	0.000493	CcSEcCtD
Methazolamide—Anaphylactic shock—Methotrexate—breast cancer	6.65e-05	0.000489	CcSEcCtD
Methazolamide—Asthenia—Docetaxel—breast cancer	6.62e-05	0.000487	CcSEcCtD
Methazolamide—Convulsion—Epirubicin—breast cancer	6.61e-05	0.000486	CcSEcCtD
Methazolamide—Ill-defined disorder—Doxorubicin—breast cancer	6.55e-05	0.000481	CcSEcCtD
Methazolamide—Nausea—Paclitaxel—breast cancer	6.47e-05	0.000475	CcSEcCtD
Methazolamide—Discomfort—Epirubicin—breast cancer	6.42e-05	0.000472	CcSEcCtD
Methazolamide—Asthenia—Capecitabine—breast cancer	6.41e-05	0.000471	CcSEcCtD
Methazolamide—Malaise—Doxorubicin—breast cancer	6.36e-05	0.000468	CcSEcCtD
Methazolamide—Vertigo—Doxorubicin—breast cancer	6.34e-05	0.000466	CcSEcCtD
Methazolamide—Anorexia—Methotrexate—breast cancer	6.34e-05	0.000466	CcSEcCtD
Methazolamide—Leukopenia—Doxorubicin—breast cancer	6.32e-05	0.000464	CcSEcCtD
Methazolamide—Diarrhoea—Docetaxel—breast cancer	6.31e-05	0.000464	CcSEcCtD
Methazolamide—Confusional state—Epirubicin—breast cancer	6.28e-05	0.000461	CcSEcCtD
Methazolamide—Anaphylactic shock—Epirubicin—breast cancer	6.22e-05	0.000458	CcSEcCtD
Methazolamide—Convulsion—Doxorubicin—breast cancer	6.11e-05	0.00045	CcSEcCtD
Methazolamide—Diarrhoea—Capecitabine—breast cancer	6.11e-05	0.000449	CcSEcCtD
Methazolamide—Paraesthesia—Methotrexate—breast cancer	5.97e-05	0.000439	CcSEcCtD
Methazolamide—Discomfort—Doxorubicin—breast cancer	5.94e-05	0.000436	CcSEcCtD
Methazolamide—Anorexia—Epirubicin—breast cancer	5.93e-05	0.000436	CcSEcCtD
Methazolamide—Somnolence—Methotrexate—breast cancer	5.91e-05	0.000435	CcSEcCtD
Methazolamide—Vomiting—Docetaxel—breast cancer	5.87e-05	0.000431	CcSEcCtD
Methazolamide—Dyspepsia—Methotrexate—breast cancer	5.85e-05	0.00043	CcSEcCtD
Methazolamide—Rash—Docetaxel—breast cancer	5.82e-05	0.000428	CcSEcCtD
Methazolamide—Dermatitis—Docetaxel—breast cancer	5.81e-05	0.000427	CcSEcCtD
Methazolamide—Confusional state—Doxorubicin—breast cancer	5.81e-05	0.000427	CcSEcCtD
Methazolamide—Decreased appetite—Methotrexate—breast cancer	5.78e-05	0.000425	CcSEcCtD
Methazolamide—Headache—Docetaxel—breast cancer	5.78e-05	0.000425	CcSEcCtD
Methazolamide—Anaphylactic shock—Doxorubicin—breast cancer	5.76e-05	0.000423	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Methotrexate—breast cancer	5.74e-05	0.000422	CcSEcCtD
Methazolamide—Fatigue—Methotrexate—breast cancer	5.73e-05	0.000422	CcSEcCtD
Methazolamide—Vomiting—Capecitabine—breast cancer	5.68e-05	0.000418	CcSEcCtD
Methazolamide—Rash—Capecitabine—breast cancer	5.63e-05	0.000414	CcSEcCtD
Methazolamide—Dermatitis—Capecitabine—breast cancer	5.63e-05	0.000414	CcSEcCtD
Methazolamide—Headache—Capecitabine—breast cancer	5.6e-05	0.000412	CcSEcCtD
Methazolamide—Paraesthesia—Epirubicin—breast cancer	5.59e-05	0.000411	CcSEcCtD
Methazolamide—Somnolence—Epirubicin—breast cancer	5.53e-05	0.000407	CcSEcCtD
Methazolamide—Anorexia—Doxorubicin—breast cancer	5.49e-05	0.000404	CcSEcCtD
Methazolamide—Nausea—Docetaxel—breast cancer	5.48e-05	0.000403	CcSEcCtD
Methazolamide—Feeling abnormal—Methotrexate—breast cancer	5.48e-05	0.000403	CcSEcCtD
Methazolamide—Dyspepsia—Epirubicin—breast cancer	5.48e-05	0.000403	CcSEcCtD
Methazolamide—Decreased appetite—Epirubicin—breast cancer	5.41e-05	0.000398	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Epirubicin—breast cancer	5.37e-05	0.000395	CcSEcCtD
Methazolamide—Fatigue—Epirubicin—breast cancer	5.37e-05	0.000395	CcSEcCtD
Methazolamide—Nausea—Capecitabine—breast cancer	5.31e-05	0.00039	CcSEcCtD
Methazolamide—Urticaria—Methotrexate—breast cancer	5.28e-05	0.000388	CcSEcCtD
Methazolamide—Body temperature increased—Methotrexate—breast cancer	5.26e-05	0.000387	CcSEcCtD
Methazolamide—Paraesthesia—Doxorubicin—breast cancer	5.17e-05	0.00038	CcSEcCtD
Methazolamide—Feeling abnormal—Epirubicin—breast cancer	5.13e-05	0.000377	CcSEcCtD
Methazolamide—Somnolence—Doxorubicin—breast cancer	5.12e-05	0.000376	CcSEcCtD
Methazolamide—Dyspepsia—Doxorubicin—breast cancer	5.07e-05	0.000373	CcSEcCtD
Methazolamide—Decreased appetite—Doxorubicin—breast cancer	5.01e-05	0.000368	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Doxorubicin—breast cancer	4.97e-05	0.000366	CcSEcCtD
Methazolamide—Fatigue—Doxorubicin—breast cancer	4.97e-05	0.000365	CcSEcCtD
Methazolamide—Urticaria—Epirubicin—breast cancer	4.94e-05	0.000364	CcSEcCtD
Methazolamide—Body temperature increased—Epirubicin—breast cancer	4.92e-05	0.000362	CcSEcCtD
Methazolamide—Asthenia—Methotrexate—breast cancer	4.77e-05	0.000351	CcSEcCtD
Methazolamide—Feeling abnormal—Doxorubicin—breast cancer	4.75e-05	0.000349	CcSEcCtD
Methazolamide—Urticaria—Doxorubicin—breast cancer	4.58e-05	0.000336	CcSEcCtD
Methazolamide—Body temperature increased—Doxorubicin—breast cancer	4.55e-05	0.000335	CcSEcCtD
Methazolamide—Diarrhoea—Methotrexate—breast cancer	4.55e-05	0.000335	CcSEcCtD
Methazolamide—Asthenia—Epirubicin—breast cancer	4.47e-05	0.000328	CcSEcCtD
Methazolamide—Diarrhoea—Epirubicin—breast cancer	4.26e-05	0.000313	CcSEcCtD
Methazolamide—Vomiting—Methotrexate—breast cancer	4.23e-05	0.000311	CcSEcCtD
Methazolamide—Rash—Methotrexate—breast cancer	4.19e-05	0.000308	CcSEcCtD
Methazolamide—Dermatitis—Methotrexate—breast cancer	4.19e-05	0.000308	CcSEcCtD
Methazolamide—Headache—Methotrexate—breast cancer	4.17e-05	0.000306	CcSEcCtD
Methazolamide—Asthenia—Doxorubicin—breast cancer	4.13e-05	0.000304	CcSEcCtD
Methazolamide—Vomiting—Epirubicin—breast cancer	3.96e-05	0.000291	CcSEcCtD
Methazolamide—Nausea—Methotrexate—breast cancer	3.95e-05	0.00029	CcSEcCtD
Methazolamide—Diarrhoea—Doxorubicin—breast cancer	3.94e-05	0.00029	CcSEcCtD
Methazolamide—Rash—Epirubicin—breast cancer	3.92e-05	0.000289	CcSEcCtD
Methazolamide—Dermatitis—Epirubicin—breast cancer	3.92e-05	0.000288	CcSEcCtD
Methazolamide—Headache—Epirubicin—breast cancer	3.9e-05	0.000287	CcSEcCtD
Methazolamide—Nausea—Epirubicin—breast cancer	3.7e-05	0.000272	CcSEcCtD
Methazolamide—Vomiting—Doxorubicin—breast cancer	3.66e-05	0.000269	CcSEcCtD
Methazolamide—Rash—Doxorubicin—breast cancer	3.63e-05	0.000267	CcSEcCtD
Methazolamide—Dermatitis—Doxorubicin—breast cancer	3.63e-05	0.000267	CcSEcCtD
Methazolamide—Headache—Doxorubicin—breast cancer	3.61e-05	0.000265	CcSEcCtD
Methazolamide—Nausea—Doxorubicin—breast cancer	3.42e-05	0.000252	CcSEcCtD
Methazolamide—CYP2C9—Metabolism—NCOA3—breast cancer	4.28e-06	4.94e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NCOA1—breast cancer	4.27e-06	4.94e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PHGDH—breast cancer	4.26e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—FHL2—breast cancer	4.26e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—UMPS—breast cancer	4.26e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADSL—breast cancer	4.26e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NME1—breast cancer	4.26e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC2A2—breast cancer	4.25e-06	4.9e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—PIK3CA—breast cancer	4.24e-06	4.89e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—STK11—breast cancer	4.21e-06	4.87e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP19A1—breast cancer	4.21e-06	4.87e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.2e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCG2—breast cancer	4.2e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CPT1A—breast cancer	4.2e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTR—breast cancer	4.2e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—BRIP1—breast cancer	4.17e-06	4.82e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LDHB—breast cancer	4.17e-06	4.82e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HPSE—breast cancer	4.17e-06	4.82e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CPT1A—breast cancer	4.16e-06	4.8e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTR—breast cancer	4.16e-06	4.8e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCG2—breast cancer	4.16e-06	4.8e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HPGDS—breast cancer	4.11e-06	4.75e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP17A1—breast cancer	4.11e-06	4.74e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HBA1—breast cancer	4.09e-06	4.72e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HPGDS—breast cancer	4.08e-06	4.71e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ENO1—breast cancer	4.07e-06	4.7e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS1—breast cancer	4.07e-06	4.7e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—PIK3CA—breast cancer	4.06e-06	4.69e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HBA1—breast cancer	4.05e-06	4.68e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.05e-06	4.68e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	4e-06	4.62e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTT1—breast cancer	3.99e-06	4.61e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ACHE—breast cancer	3.99e-06	4.61e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2D6—breast cancer	3.99e-06	4.61e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCC1—breast cancer	3.96e-06	4.57e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTA3—breast cancer	3.96e-06	4.57e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMMR—breast cancer	3.96e-06	4.57e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTT1—breast cancer	3.96e-06	4.57e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ACHE—breast cancer	3.96e-06	4.57e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—COMT—breast cancer	3.92e-06	4.52e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NCOA2—breast cancer	3.91e-06	4.52e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTP1—breast cancer	3.9e-06	4.5e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—PIK3CA—breast cancer	3.89e-06	4.5e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMOX1—breast cancer	3.84e-06	4.44e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ITPR1—breast cancer	3.84e-06	4.43e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.83e-06	4.43e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—FASN—breast cancer	3.8e-06	4.38e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—BCHE—breast cancer	3.78e-06	4.37e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP17A1—breast cancer	3.78e-06	4.36e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP17A1—breast cancer	3.74e-06	4.33e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS1—breast cancer	3.74e-06	4.32e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ENO1—breast cancer	3.74e-06	4.32e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC5A5—breast cancer	3.73e-06	4.31e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS1—breast cancer	3.71e-06	4.28e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ENO1—breast cancer	3.71e-06	4.28e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.69e-06	4.27e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCB1—breast cancer	3.69e-06	4.26e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.65e-06	4.21e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2D6—breast cancer	3.64e-06	4.2e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TYMS—breast cancer	3.62e-06	4.19e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTA4—breast cancer	3.62e-06	4.18e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CA9—breast cancer	3.62e-06	4.18e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NQO1—breast cancer	3.61e-06	4.16e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC2A1—breast cancer	3.61e-06	4.16e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NCOA2—breast cancer	3.6e-06	4.16e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PLA2G4A—breast cancer	3.58e-06	4.14e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTM1—breast cancer	3.58e-06	4.14e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NCOR1—breast cancer	3.58e-06	4.14e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NCOA2—breast cancer	3.57e-06	4.12e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.53e-06	4.08e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX2—breast cancer	3.53e-06	4.07e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTA2—breast cancer	3.53e-06	4.07e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP3A4—breast cancer	3.52e-06	4.06e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.5e-06	4.04e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—FASN—breast cancer	3.49e-06	4.03e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX4—breast cancer	3.48e-06	4.02e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SULT1A1—breast cancer	3.48e-06	4.02e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—BCHE—breast cancer	3.48e-06	4.02e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AKT1—breast cancer	3.46e-06	4e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—FASN—breast cancer	3.46e-06	4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP1B1—breast cancer	3.46e-06	3.99e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—BCHE—breast cancer	3.45e-06	3.98e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC5A5—breast cancer	3.43e-06	3.97e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GPX1—breast cancer	3.43e-06	3.96e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—PIK3CA—breast cancer	3.42e-06	3.95e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC5A5—breast cancer	3.4e-06	3.93e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTA1—breast cancer	3.4e-06	3.93e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—IDH1—breast cancer	3.4e-06	3.93e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP1A1—breast cancer	3.4e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.39e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ERCC2—breast cancer	3.37e-06	3.89e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NAT2—breast cancer	3.36e-06	3.89e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AKT1—breast cancer	3.32e-06	3.83e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NQO1—breast cancer	3.32e-06	3.83e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC2A1—breast cancer	3.32e-06	3.83e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NCOA1—breast cancer	3.3e-06	3.81e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NQO1—breast cancer	3.29e-06	3.8e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC2A1—breast cancer	3.29e-06	3.8e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—STK11—breast cancer	3.25e-06	3.75e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP19A1—breast cancer	3.25e-06	3.75e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP3A4—breast cancer	3.23e-06	3.74e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.22e-06	3.72e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP3A4—breast cancer	3.21e-06	3.7e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.19e-06	3.68e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AKT1—breast cancer	3.18e-06	3.68e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP1B1—breast cancer	3.18e-06	3.67e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—breast cancer	3.17e-06	3.66e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP1B1—breast cancer	3.15e-06	3.64e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.12e-06	3.6e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.09e-06	3.57e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.05e-06	3.52e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NCOA1—breast cancer	3.03e-06	3.5e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—COMT—breast cancer	3.02e-06	3.49e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTP1—breast cancer	3.01e-06	3.47e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NCOA1—breast cancer	3.01e-06	3.47e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—STK11—breast cancer	2.99e-06	3.45e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP19A1—breast cancer	2.99e-06	3.45e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMOX1—breast cancer	2.97e-06	3.43e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP19A1—breast cancer	2.96e-06	3.42e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—STK11—breast cancer	2.96e-06	3.42e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ITPR1—breast cancer	2.96e-06	3.42e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MED12—breast cancer	2.95e-06	3.41e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—DPYD—breast cancer	2.95e-06	3.41e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CAV1—breast cancer	2.92e-06	3.37e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDOA—breast cancer	2.9e-06	3.35e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCB1—breast cancer	2.85e-06	3.29e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOA3—breast cancer	2.82e-06	3.26e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC2A2—breast cancer	2.8e-06	3.23e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AKT1—breast cancer	2.8e-06	3.23e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TYMS—breast cancer	2.8e-06	3.23e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.78e-06	3.21e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—COMT—breast cancer	2.78e-06	3.21e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTP1—breast cancer	2.77e-06	3.19e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NCOR1—breast cancer	2.76e-06	3.19e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTM1—breast cancer	2.76e-06	3.19e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.76e-06	3.19e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—COMT—breast cancer	2.76e-06	3.18e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CPT1A—breast cancer	2.74e-06	3.17e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCG2—breast cancer	2.74e-06	3.17e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTR—breast cancer	2.74e-06	3.17e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTP1—breast cancer	2.74e-06	3.17e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMOX1—breast cancer	2.73e-06	3.15e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ITPR1—breast cancer	2.72e-06	3.14e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMOX1—breast cancer	2.7e-06	3.12e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ITPR1—breast cancer	2.7e-06	3.12e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HPGDS—breast cancer	2.69e-06	3.11e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HBA1—breast cancer	2.67e-06	3.09e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CG—breast cancer	2.66e-06	3.07e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GPX1—breast cancer	2.65e-06	3.06e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP1A1—breast cancer	2.62e-06	3.03e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCB1—breast cancer	2.62e-06	3.02e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTT1—breast cancer	2.61e-06	3.01e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ACHE—breast cancer	2.61e-06	3.01e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ERCC2—breast cancer	2.6e-06	3e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCB1—breast cancer	2.6e-06	3e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TYMS—breast cancer	2.57e-06	2.97e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TYMS—breast cancer	2.55e-06	2.94e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NCOR1—breast cancer	2.54e-06	2.94e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTM1—breast cancer	2.54e-06	2.94e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.54e-06	2.94e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTM1—breast cancer	2.52e-06	2.91e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.52e-06	2.91e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NCOR1—breast cancer	2.52e-06	2.91e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP17A1—breast cancer	2.47e-06	2.85e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ENO1—breast cancer	2.44e-06	2.82e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS1—breast cancer	2.44e-06	2.82e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—breast cancer	2.44e-06	2.82e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GPX1—breast cancer	2.43e-06	2.81e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GPX1—breast cancer	2.41e-06	2.79e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP1A1—breast cancer	2.41e-06	2.78e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2D6—breast cancer	2.4e-06	2.77e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ERCC2—breast cancer	2.39e-06	2.76e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP1A1—breast cancer	2.39e-06	2.76e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ERCC2—breast cancer	2.37e-06	2.74e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOA2—breast cancer	2.35e-06	2.72e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CD—breast cancer	2.34e-06	2.7e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALB—breast cancer	2.31e-06	2.67e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—FASN—breast cancer	2.28e-06	2.64e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—BCHE—breast cancer	2.27e-06	2.63e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CAV1—breast cancer	2.25e-06	2.6e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—breast cancer	2.25e-06	2.59e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC5A5—breast cancer	2.25e-06	2.59e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—breast cancer	2.23e-06	2.57e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NOS3—breast cancer	2.21e-06	2.55e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NQO1—breast cancer	2.17e-06	2.5e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC2A1—breast cancer	2.17e-06	2.5e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.15e-06	2.49e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP1B1—breast cancer	2.08e-06	2.4e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CAV1—breast cancer	2.07e-06	2.39e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CAV1—breast cancer	2.05e-06	2.37e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CG—breast cancer	2.05e-06	2.37e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.04e-06	2.35e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CB—breast cancer	2.04e-06	2.35e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—breast cancer	2.02e-06	2.33e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOA1—breast cancer	1.98e-06	2.29e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.96e-06	2.27e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—STK11—breast cancer	1.95e-06	2.26e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP19A1—breast cancer	1.95e-06	2.26e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CG—breast cancer	1.89e-06	2.18e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CG—breast cancer	1.87e-06	2.16e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—COMT—breast cancer	1.82e-06	2.1e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTP1—breast cancer	1.81e-06	2.09e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CD—breast cancer	1.8e-06	2.08e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMOX1—breast cancer	1.78e-06	2.06e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALB—breast cancer	1.78e-06	2.06e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ITPR1—breast cancer	1.78e-06	2.06e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTEN—breast cancer	1.76e-06	2.03e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCB1—breast cancer	1.71e-06	1.98e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NOS3—breast cancer	1.7e-06	1.97e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TYMS—breast cancer	1.68e-06	1.94e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.66e-06	1.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOR1—breast cancer	1.66e-06	1.92e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTM1—breast cancer	1.66e-06	1.92e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CD—breast cancer	1.66e-06	1.92e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CD—breast cancer	1.64e-06	1.9e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALB—breast cancer	1.64e-06	1.89e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALB—breast cancer	1.62e-06	1.88e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX1—breast cancer	1.59e-06	1.84e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP1A1—breast cancer	1.58e-06	1.82e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CB—breast cancer	1.57e-06	1.82e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NOS3—breast cancer	1.57e-06	1.81e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ERCC2—breast cancer	1.56e-06	1.8e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—breast cancer	1.56e-06	1.8e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NOS3—breast cancer	1.55e-06	1.79e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—breast cancer	1.47e-06	1.7e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CB—breast cancer	1.45e-06	1.67e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CB—breast cancer	1.43e-06	1.66e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—breast cancer	1.43e-06	1.66e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—breast cancer	1.42e-06	1.64e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTEN—breast cancer	1.36e-06	1.57e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CAV1—breast cancer	1.35e-06	1.56e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTEN—breast cancer	1.25e-06	1.44e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3CA—breast cancer	1.24e-06	1.44e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTEN—breast cancer	1.24e-06	1.43e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.23e-06	1.43e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.08e-06	1.25e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALB—breast cancer	1.07e-06	1.24e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NOS3—breast cancer	1.02e-06	1.18e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKT1—breast cancer	1.01e-06	1.17e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3CA—breast cancer	9.59e-07	1.11e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CB—breast cancer	9.46e-07	1.09e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—breast cancer	9.37e-07	1.08e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3CA—breast cancer	8.82e-07	1.02e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3CA—breast cancer	8.74e-07	1.01e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTEN—breast cancer	8.17e-07	9.44e-06	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKT1—breast cancer	7.83e-07	9.04e-06	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKT1—breast cancer	7.2e-07	8.32e-06	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKT1—breast cancer	7.14e-07	8.25e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3CA—breast cancer	5.76e-07	6.66e-06	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKT1—breast cancer	4.71e-07	5.44e-06	CbGpPWpGaD
